✦ LIBER ✦

O10 SAFETY AND EFFICACY OF THE ALL-ORAL REGIMEN OF MK-5172/MK-8742 ± RIBAVIRIN IN TREATMENT-NAIVE, NON-CIRRHOTIC, PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION: THE C-WORTHY STUDY

✍ Scribed by Hezode, C.; Serfaty, L.; Vierling, J.M.; Kugelmas, M.; Pearlman, B.; Sievert, W.; Ghesquiere, W.; Zuckerman, E.; Sund, F.; Shaughnessy, M.; Hwang, P.; Wahl, J.; Robertson, M.N.; Haber, B.

Book ID: 122141487
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 64 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)60012-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O61 EFFICACY AND SAFETY OF MK-5172 AND M

O61 EFFICACY AND SAFETY OF MK-5172 AND MK-8742 ± RIBAVIRIN IN HEPATITIS C GENOTYPE 1 INFECTED PATIENTS WITH CIRRHOSIS OR PREVIOUS NULL-RESPONSE: THE C-WORTHY STUDY

✍ Lawitz, E.; Hezode, C.; Gane, E.; Tam, E.; Lagging, M.; Balart, L.; Rossaro, L.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 79 KB

O63 EFFICACY AND SAFETY OF THE ALL-ORAL

O63 EFFICACY AND SAFETY OF THE ALL-ORAL REGIMEN, MK-5172/MK-8742 +/− RBV FOR 12 WEEKS IN GT1 HCV/HIV CO-INFECTED PATIENTS: THE C-WORTHY STUDY

✍ Sulkowski, M.; Mallolas, J.; Pol, S.; Bourliere, M.; Gerstoft, J.; Shibolet, O.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

P1233 EFFICACY AND SAFETY OF MK-5172 PLU

P1233 EFFICACY AND SAFETY OF MK-5172 PLUS RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION: FINAL RESULTS OF THE C-SPIRIT STUDY

✍ Gane, E.; Ben Ari, Z.; Mollison, L.; Zuckerman, E.; Bruck, R.; Baruch, Y.; Wahl, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 56 KB

P1234 SAFETY AND EFFICACY OF MK-5172 PLU

P1234 SAFETY AND EFFICACY OF MK-5172 PLUS PEGINTERFERON ALFA-2b AND RIBAVIRIN (PR) IN CIRRHOTIC AND NON-CIRRHOTIC TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS (HCV) GENOTYPE (G)1 INFECTION

✍ Hezode, C.; Bruno, S.; Jacobson, I.; Serfaty, L.; Kwo, P.; Zhou, A.; Gilbert, C. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB